We study ethical challenges in behavioral healthcare & propose solutions. Hastings Center ReportExperiential Training in Psychedelic-Assisted Therapy: A Risk-Benefit AnalysisDaniel Rosenbaum, Crystal Hare, Emma Hapke, Yarissa Herman, Susan Abbey, Dominic Sisti, PhD, Daniel BuchmanAugust 2024 Read this entry Harvard Review of PsychiatryPsychiatric Hospitals and the Ethics of Salutogenic Design: The Return of Moral Architecture?Meggie Crnic, PhD, Stephanie Bi, Philip J. Candilis, Dominic Sisti, PhDJuly 2024 Read this entry JAMA Network OpenDeveloping an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus StatementAmy McGuire, JD, PhD, I. Glenn Cohen, JD, Dominic Sisti, PhD, et al.June 2024 Read this entry Perspectives in Biology and MedicineBio-Psycho-Spiritual Perspectives on PsychedelicsLogan Neitzke-Spruill, Neşe Devenot, Dominic Sisti, PhD, Lynnette A. Averill, Amy McGuire, JD, PhDFebruary 2024 Read this entry Nature MedicineThe safety of supported psilocybin use in OregonWilliam Smith, MD, PhD, Dominic Sisti, PhD, Paul Appelbaum, MDJanuary 2024 Read this entry Medpage TodayClarifying the 'Duty to Warn' in North CarolinaScott Polick, MD, Carrie Polick, PhD, Dominic Sisti, PhD, Paul Appelbaum, MDSeptember 2023 Read this entry Perspectives in Biology and MedicinePast Is Prologue: Ethical Issues in Pediatric Psychedelics Research and TreatmentGail A. Edelsohn, MD, MSPH, Dominic Sisti, PhDMarch 2023 Read this entry AJOB NeuroethicsJourneying to Ixtlan: Ethics of Psychedelic Medicine and Research for Alzheimer’s Disease and Related DementiasAndrew Peterson, PhD, Emily A. Largent, Holly Fernandez Lynch, JD, MBE, Jason Karlawish, MD, Dominic Sisti, PhDDecember 2022 Read this entry Cambridge Quarterly of Healthcare EthicsSkip the Trip? Five Arguments on the Use of Nonhallucinogenic Psychedelics in PsychiatryDominic Sisti, PhD, Andrew Peterson, PhDNovember 2022 Read this entry